Back to top
more

Align Technology (ALGN)

(Delayed Data from NSDQ)

$212.15 USD

212.15
651,165

+1.37 (0.65%)

Updated Nov 5, 2024 04:00 PM ET

After-Market: $211.69 -0.46 (-0.22%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Dental Supplies

Zacks News

Why Investors Should Buy Edwards Lifesciences (EW) Right Now

Leading CA-based medical equipment major Edwards Lifesciences Corporation (EW) is currently on a healthy growth trajectory.

    Why Quest Diagnostics (DGX) is a Suitable Pick for Investors

    Madison, NJ-based Quest Diagnostics, Inc. (DGX), a provider of commercial laboratory services, has been on a growth trajectory of late.

      Lantheus (LNTH) Scores a Strong Buy Right Now: Here's How

      Lantheus Holdings, Inc. (LNTH) has rallied 28.2% over the last three months, ahead of the S&P 500's 4.3% gain.

        Baxter (BAX) Scales 52-Week High: What's Behind the Rally

        Baxter International Inc. (BAX) scaled a new 52-week high of $60.47 on Jun 21, closing a bit lower at $60.05.

          GNC Holdings Continues to Gain from New GNC, Global Revenue

          On Jun 20 2017, we issued an updated research report on Pittsburgh, PA-based GNC Holdings, Inc. (GNC).

            PerkinElmer (PKI) to Acquire German Firm EUROIMMUN for $1.3B

            PerkinElmer Inc. (PKI) recently announced that it will acquire EUROIMMUN Medical Laboratory Diagnostics AG for approximately $1.3 billion in cash.

              PAREXEL Announces Acquisition by Pamplona Capital for $5B

              PAREXEL International Corporation (PRXL) recently announced that it has agreed to be acquired by Pamplona Capital Management, LLP.

                Why Investors Should Retain Molina Healthcare (MOH) Stock

                Molina Healthcare, Inc. (MOH) consistent operating performance is backed by its steady increase in premiums and service revenues, effective inorganic growth initiatives and solid fundamentals.

                  Teladoc (TDOC) to Raise Debt for Best Doctors Acquisition

                  Teladoc, Inc. (TDOC) announced recently that it would offer senior notes worth $200 million, with the year of maturity fixed as 2022.

                    Medtronic CRT Devices Improve Therapy Delivery, Cut Costs

                    Medtronic plc (MDT) recently announced positive data on cardiac resynchronization therapy (CRT) devices within its Cardiac and Vascular segment.

                      Hologic (HOLX) Gets FDA Clearance for Aptima HSV 1 & 2 Test

                      Hologic, Inc. (HOLX) recently received FDA approval for the commercial launch of the Aptima Herpes Simplex Virus (HSV) 1 & 2 molecular assay on the fully automated Panther system.

                        Genomic Health Cancer Tests Strong, Operating Expenses a Woe

                        On Jun 19, we issued an updated research report on Redwood City, CA-based Genomic Health Inc (GHDX), a global cancer research company with a focus on advanced molecular diagnostics.

                          Walgreens-Greater Than AIDS Unite to Serve Against HIV/AIDS

                          Walgreens Boots Alliance, Inc. (WBA) recently teamed up with Greater Than AIDS, a national public information response, focused on the U.S. domestic HIV/AIDS epidemic.

                            Teladoc (TDOC) to Buy Best Doctors, Stock Hits New High

                            Teladoc Inc. (TDOC) has inked a definitive agreement to acquire Best Doctors, a leader in medical consultation.

                              Align Technology (ALGN) Enters the S&P 500 Index, Stock Up

                              Align Technology, Inc. (ALGN), the California-based dental major has joined the coveted S&P 500 benchmark, after the market closed on Jun 16.

                                Luminex (LMNX) Scores a Strong Buy Right Now: Here's How

                                With solid growth prospects, Luminex Corporation (LMNX) carries a Zacks Rank #1 (Strong Buy) which is an attractive pick at present.

                                  ResMed (RMD) at 52-Week High: What's Driving the Stock?

                                  Share price of ResMed Inc. (RMD) scaled a new 52-week high of $79.22 on Jun 19, eventually closing a bit lower at $78.91.

                                    PAREXEL to Launch Connected Journey Data-Driven Services

                                    PAREXEL International Corporation (PRXL) recently announced the launch of its proprietary data-driven services, Connected Journey.

                                      Medtronic Posts Positive Result on Reactive ATP, Grows in AF

                                      Medtronic's (MDT) Reactive ATP therapy slows the progression of AF in patients who are being implanted with cardiac devices.

                                        Zacks.com featured highlights: Gray Television, H&R Block, Align Technology, Raymond James Financial and KLA-Tencor

                                        Zacks.com featured highlights: Gray Television, H&R Block, Align Technology, Raymond James Financial and KLA-Tencor

                                          Universal Health Grows on Acquisitions, Rising Debt a Drag

                                          Universal Health Services, Inc.'s (UHS)s inorganic strategies substantially make it well positioned for long-term growth.

                                            Inogen (INGN) Scores a Strong Buy Right Now: Here's How

                                            Goleta, CA-based Inogen Inc. (INGN), a provider of portable oxygen concentrators (POC), is on a healthy growth trajectory of late.

                                              Hologic Receives Extended FDA Clearance for SculpSure in US

                                              Hologic, Inc. (HOLX) declared that the company's subsidiary Cynosure has received FDA's expanded clearance for SculpSure.

                                                Why Does Intuitive Surgical Score as a Strong Buy Right Now

                                                Over the last three months, Intuitive Surgical Inc. (ISRG) was trading consistently ahead of the S&P 500 Index.

                                                  5 Momentum Stocks to Scoop Up Gains Using Driehaus Strategy

                                                  Risk-taking investors may use Driehaus Strategy to get strong returns by investing in momentum stocks.